Category: Latest News

  • ZIM shares tick higher as the carrier tops profit forecasts despite steep rate drops

    ZIM shares tick higher as the carrier tops profit forecasts despite steep rate drops

    ZIM Integrated Shipping Services Ltd. (NYSE:ZIM) saw its stock inch up in premarket trading Thursday after the container carrier delivered third-quarter earnings that beat Wall Street estimates, even as it grappled with sharply lower freight prices and reduced shipping volumes. Shares were up 0.96% after ZIM reported adjusted earnings of $1.02 per share, ahead of…

  • Cato Corp drops nearly 6% after Q3 results fall short despite narrower loss

    Cato Corp drops nearly 6% after Q3 results fall short despite narrower loss

    Cato Corporation (NYSE:CATO) shares declined sharply in premarket trading Thursday after the apparel retailer posted third-quarter results that, while improved from last year, still failed to meet market expectations. The stock slid 5.85% after Cato reported a quarterly net loss of –$0.28 per share, a notable improvement from the –$0.79 loss recorded in the same…

  • Construction Partners drops 4% as Q4 profit miss outweighs strong revenue surge

    Construction Partners drops 4% as Q4 profit miss outweighs strong revenue surge

    Construction Partners, Inc. (NASDAQ:ROAD) slid in premarket trading on Thursday after the company’s latest quarterly results showed a profit shortfall, overshadowing an otherwise strong top-line performance. Shares were down 4.69% after the civil infrastructure specialist reported adjusted fourth-quarter earnings of $1.02 per share, below Wall Street’s $1.09 estimate. Revenue, however, reached $899.5 million, comfortably ahead…

  • Evogene shares climb 5% as cost reductions help deliver earnings beat

    Evogene shares climb 5% as cost reductions help deliver earnings beat

    Evogene Ltd. (NASDAQ:EVGN) traded sharply higher on Thursday after the company posted third-quarter results that topped profit expectations, even as revenue came in well below forecasts. Shares of the computational chemistry and AI-driven small-molecule design firm rose 5.13% in premarket trading following the announcement. For the quarter, Evogene reported a net loss of $0.31 per…

  • Vizsla Silver shares drop as company prices $250 million convertible notes offering

    Vizsla Silver shares drop as company prices $250 million convertible notes offering

    Vizsla Silver Corp. (AMEX:VZLA) saw its stock tumble on Thursday after announcing the pricing of a $250 million issue of convertible senior unsecured notes. The stock slid 13% in premarket trading, falling to $4.05 compared with Wednesday’s close of $4.67. The notes carry an interest rate of 5.00%, mature in 2031, and can initially be…

  • Shoe Carnival shares inch higher as Q3 revenue tops forecasts

    Shoe Carnival shares inch higher as Q3 revenue tops forecasts

    Shoe Carnival, Inc. (NASDAQ:SCVL) traded modestly higher in premarket action Thursday after the footwear retailer delivered third-quarter results that beat revenue expectations while matching Wall Street’s earnings forecast. The company reported Q3 revenue of $297.2 million, slightly above the consensus estimate of $295.7 million, though sales were down 3.2% from the year-ago period. Shares rose…

  • Bath & Body Works plunges 16% after trimming outlook and missing Q3 expectations

    Bath & Body Works plunges 16% after trimming outlook and missing Q3 expectations

    Bath & Body Works (NYSE:BBWI) saw its shares tumble in premarket trading on Thursday, sliding more than 16% after the retailer lowered its full-year guidance and delivered third-quarter results that fell short of Wall Street forecasts. For Q3, the company posted earnings of $0.35 per share, missing analysts’ expectations of $0.40, while revenue came in…

  • Moderna shares climb as company maps out three-year plan and targets 10% revenue growth by 2026

    Moderna shares climb as company maps out three-year plan and targets 10% revenue growth by 2026

    Moderna (NASDAQ:MRNA) gained 3% on Thursday after presenting a new multi-year roadmap at its Analyst Day, detailing how it intends to expand its vaccine portfolio and accelerate progress in oncology. The biotech company said it is aiming for up to 10% revenue growth in 2026, supported by its seasonal vaccine franchise and a stronger late-stage…

  • ZKH Group falls short on Q3 revenue as marketplace contribution declines

    ZKH Group falls short on Q3 revenue as marketplace contribution declines

    ZKH Group Limited (NYSE:ZKH), a key player in China’s maintenance, repair, and operations (MRO) procurement sector, posted third-quarter results on Thursday that came in below Wall Street expectations. The stock slipped 0.33% in pre-market trading after the release. The company generated $319.43 million in revenue, well under the $363.54 million consensus forecast. Although ZKH recorded…

  • Jacobs Solutions tops Q4 expectations and projects double-digit EPS growth for 2026

    Jacobs Solutions tops Q4 expectations and projects double-digit EPS growth for 2026

    Jacobs Solutions Inc. (NYSE:J) delivered stronger-than-expected fiscal fourth-quarter results on Thursday, lifting its shares 1.6% in early trading after the release. The company reported adjusted EPS of $1.75, ahead of the $1.67 analysts were looking for. Revenue for the quarter ended September 26, 2025, came in at $3.2 billion, beating the $3.15 billion consensus estimate…